An Observational Study Evaluating the Productivity and Health-Related Quality of Life of People With HER2 Positive Breast Cancer

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

December 12, 2016

Primary Completion Date

March 17, 2017

Study Completion Date

March 17, 2017

Conditions
Breast Neoplasms
Interventions
OTHER

No Intervention

Trial Locations (14)

NP7 7EG

Nevill Hall Hospital, Abergavenny

CO4 5JL

Colchester General Hospital, Colchester, Essex

EX2 5DW

Royal Devon & Exeter Hospital; Oncology Centre, Exeter

GU2 7XX

Royal Surrey County Hospital, Guildford

IP4 5PD

Ipswich Hospital; Clinical Oncology, Ipswich

EC1A 7BE

Barts and the London NHS Trust., London

SW17 0QT

St George's Hospital, London

M20 4QL

Christie Hospital; Breast Cancer Research Office, Manchester

NE7 7DN

Freeman Hospital, Newcastle upon Tyne

HA6 2RN

Mount Vernon Cancer Centre, Northwood

NG5 1PB

Nottingham City Hospital; Oncology, Nottingham

TR1 3LJ

Royal Cornwall Hospital, Truro

WF1 4DG

Pinderfields General Hospital, Wakefield

BA21 4AT

Yeovil District Hospital; Macmillan Cancer Unit, Yeovil

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT03099200 - An Observational Study Evaluating the Productivity and Health-Related Quality of Life of People With HER2 Positive Breast Cancer | Biotech Hunter | Biotech Hunter